Company Newron Pharmaceuticals SpA CBOE EUROPE EQUITIES
Equities
0QOI
IT0004147952
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CHF | - |
|
Business Summary
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Drugs
100.0
%
| 6 | 100.0 % | 9 | 100.0 % | +43.85% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Italy & United States
100.0
%
| 6 | 100.0 % | 9 | 100.0 % | +43.85% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stefan Weber
CEO | Chief Executive Officer | 60 | 12-05-14 |
Luca Benatti
FOU | Founder | 63 | 97-12-31 |
Roberto Galli
DFI | Director of Finance/CFO | - | 01-12-31 |
Filippo Moriggia
COO | Chief Operating Officer | - | 16-10-31 |
Ravi Anand
CTO | Chief Tech/Sci/R&D Officer | 67 | 04-12-31 |
Laura Faravelli
PRN | Corporate Officer/Principal | - | 18-12-31 |
Dennis Dionne
PRN | Corporate Officer/Principal | - | 14-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 07-12-31 | |
Luca Benatti
FOU | Founder | 63 | 97-12-31 |
Ulrich Köstlin
CHM | Chairman | 71 | 12-12-31 |
Stefan Weber
CEO | Chief Executive Officer | 60 | 12-05-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,631,834 | 16,874,414 ( 90.57 %) | 0 | 90.57 % |
Company contact information
![address Newron Pharmaceuticals SpA(0QOI)](https://cdn.zonebourse.com/static/address/16417982.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+2.99% | 95.18B | |
-4.34% | 37.55B | |
-10.41% | 33.75B | |
+75.79% | 28.2B | |
-14.61% | 15.63B | |
-3.46% | 13.63B | |
-12.31% | 11.5B | |
+184.77% | 10.81B | |
-54.13% | 9.23B |
- Stock Market
- Equities
- NWRN Stock
- 0QOI Stock
- Company Newron Pharmaceuticals SpA